ALR Technologies Adds Board Members, Readies for Commercialization

Following news from last week that it has completed the development phase for its Health-e-Connect system, a universal platform for remote monitoring of chronic disease, ALR Technologies (OTCBB: ALRT) said this morning that it has added new members to its Board of Directors.  The company also reported that board member and VP of Technology Jaroslav V. Tichy, PhD, will be retiring from those positions and now serve as a consultant to ALRT.  Tichy, who is now 71 years old, played a key role in the developmental stage of the technology.  With that stage completed, Tichy will retire from the full-time role, according to the news.

With the additions, it is discernible that the company has added a strong financial background with the addition of Ken Robulak and a strong clinical and medical administration lineage with Dr. Alfonso Salas.

Today’s press release:

ALR Technologies Announces New Board Members

RICHMOND, VA — (Marketwire) — 09/04/12 — ALR Technologies Inc. (OTCBB: ALRT) (the “Company”), a health information technology developer, is pleased to announce the appointment of Alfonso M. Salas, M.D. and Kenneth J. Robulak to its Board of Directors.

Dr. Salas has extensive experience across the medical industry, including consulting, managing clinical trials, disease management and preventative services. He served as the Medical Director in the office of the Ministry of Social Security and Labor in Colombia and managed the Occupational Health department. Additionally, Dr. Salas was a consultant for El Prado Medical Clinic and private medical offices which provided services to private medical insurances as well as to the Province of Magdalena, Colombia. Presently, he operates his own business consulting corporations on budgets, research and medical services.

Dr. Salas received his medical degree with distinction from Universidad Metroplitana of Barranquilla, Colombia.

Mr. Robulak earned a Bachelor of Commerce degree from the University of Calgary and F.I.C.B. (Fellow, Institute of Canadian Bankers) from the University of British Columbia. He worked in corporate and investment banking for 30 years and more recently worked as a consultant in the manufacturing industry. Currently, Mr. Robulak assists a Mexico-based company with its marketing in the United States through its office in Dallas.

Concurrent with the addition of the new board members, the Company also announces the retirement of Jaroslav V. Tichy, PhD, as Vice President of Technology and board member at ALR Technologies. Dr. Tichy will still serve as a consultant to the Company.

“We are very pleased with the additions of Dr. Salas and Mr. Robulak to our Board of Directors. Their deep knowledge in their respective industries of medical administration and finance will prove invaluable as we transition into a revenue-stage company,” commented Sidney Chan, Chairman and Chief Executive Officer at ALR Technologies. “Dr. Tichy has been integral to the development of our company for many years. We wish him the best of luck in his retirement and thank him for his tireless commitment to bring our Health-e-Connect system and universal cable to fruition.”

“It has been a primary goal of mine to see the Health-e-Connect system and universal cable reach commercialization before my retirement,” said Dr. Tichy. “I am excited to assume a different role as a consultant to assist in the continued growth of the Company.”

About ALR Technologies Inc.

ALRT Health-e-Connect System (“System”) is the principal product of the Company. Heath-e-Connect is a web based patient management platform for medical professionals to improve compliance and adherence of care plans of patients in their homes. The System is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at

ALR Technologies: 804-554-3500 Ext. 704           e-mail: [email protected]

This release contains certain “forward-looking statements” relating to ALR Technologies’ business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words “estimate”, “expect”, “anticipate”, “believe” and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company’s quarterly filings with the Securities Exchange Commission.

ALR Technologies:

804-554-3500 Ext. 704

e-mail: [email protected]

ALR Technologies (ALRT) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated three thousand dollars for one month of consultation and journalism services and to manage an investor relations/awareness program by ALR Technologies. Viper has completed prior service agreements with ALRT Technologies with full disclosure listed on our disclaimer/disclosure page. Please read and fully understand our entire disclaimer at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Stocks Struggle for a Reason to Move on Tuesday

Stocks Struggle for a Reason to Move on Tuesday(0)

American stocks were mixed with the Dow edging lower and the S&P 500 and Nasdaq squeaking ahead on Tuesday as a lack of conviction kept investors on the sidelines. Sentiment is torn ahead of quarterly reports starting to flow in and the euro zone’s financial turmoil as Spain is in focus in need of a

Markets End Mixed on First Day of Fourth Quarter

Markets End Mixed on First Day of Fourth Quarter(0)

A rally on Wall Street lost steam Monday afternoon following comments from Federal Reserve chairman Ben Bernanke. Stocks had started the day strong as data from the Institute for Supply Management showed that its manufacturing index climbed into expansion territory for the first time after three straight months of contraction. Traders also found solace in

Cardium Increases Product Portfolio with Acquisition of To Go Brands

Cardium Increases Product Portfolio with Acquisition of To Go Brands(0)

Cardium Therapeutics (NYSE MKT: CXM) today announced that its MedPodium® operating unit has acquired the assets, business and product portfolio of privately-held To Go Brands® to support the expansion of Cardium’s health sciences nutraceutical brand platform. To Go Brands have introduced products in a number of food, drug and mass channel retailers, and the company

Touchdown!  NFL Refs Return to Field Thursday

Touchdown! NFL Refs Return to Field Thursday(0)

Not to knock the referees that filled-in during the lock-out of NFL officials as they did a pedestrian job, but the atrocious call on Monday Night Football between the Seahawks and the Packers was just about enough of the replacements.  Today, the National Football League said that a new eight-year deal with the NFL Referees

US Markets Drift Lower Ignoring Decent Economic Data

US Markets Drift Lower Ignoring Decent Economic Data(0)

U.S. stocks drifted lower Tuesday afternoon as worries about global economic growth overshadowed positive reports on the U.S. housing market and consumer confidence. The Dow Jones Industrial average was sharply lower, by 101.37 points, to finish at 13,457.50 The S&P 500 index subtracted 15.30 points, to 1,441.59, and the Nasdaq Composite Index got bruised 43.06

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.